Rockefeller Capital Management’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
Other funds holding RYTM
BBA
Rockefeller Capital Management's RYTM Position: Q3 2026 in Review
Rockefeller Capital Management reduced its Rhythm Pharmaceuticals (RYTM) stake by 7.3% in Q3 2026, selling an estimated $46.5K and leaving 5,509 shares worth $525K. The position accounts for ﹤0.01% of the portfolio, ranked #2109.
Rockefeller Capital Management first reported a position in RYTM in Q1 2019 and has held it in 9 quarters since. The position peaked at $1.26M in Q4 2025. 333 funds tracked by Wall St. Rank hold RYTM as of Q3 2026.
- Rockefeller Capital Management held 5,509 shares of Rhythm Pharmaceuticals worth $525K as of Q3 2026.
- Rockefeller Capital Management sold 436 Rhythm Pharmaceuticals shares in Q3 2026, an estimated $46.5K.
- Rhythm Pharmaceuticals made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q3 2026, its #2109 holding.
- Rockefeller Capital Management first reported a position in Rhythm Pharmaceuticals in Q1 2019 and has held it in 9 quarters since.
- Rockefeller Capital Management's Rhythm Pharmaceuticals position peaked at $1.26M in Q4 2025.
- 333 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q3 2026.
Based on Rockefeller Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.